Diane Rehm’s weekly podcast features newsmakers, writers, artists and thinkers on the issues she cares about most: what’s going on in Washington, ideas that inform, and the latest on living well as we live longer.
…
continue reading
Contenido proporcionado por Political Pharmacist and Eric Geyer. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Political Pharmacist and Eric Geyer o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !
¡Desconecta con la aplicación Player FM !
Episode 128 - Issues with Cabenuva Billingand Access withDr.Carly Floyd
MP3•Episodio en casa
Manage episode 331887042 series 3265313
Contenido proporcionado por Political Pharmacist and Eric Geyer. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Political Pharmacist and Eric Geyer o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Cabenuva seemed to be a cure for adherence issues while treating HIV, so why is accessing it so hard? Dr. Carly Floyd joins the podcast to discuss issues with Cabenuva billing that has negatively impacted many patients, providers and clinics around the US. What seems like it should be simple approval process has turned into a medical billing nightmare that limits patients access, costs some clinics to lose money and has been a major issue with how we treat HIV. Increased opacity is never good in healthcare billing. Join AAHIVM here: https://aahivm.org/ Read more on Cabenuva issues here: https://aahivm.org/wp-content/uploads/2021/03/Long-Acting-ARVs-_Final-2-25-21_PDF.pdf https://www.floridahealth.gov/diseases-and-conditions/aids/adap/_documents/FINAL5BarrierstoLA-ARVsResourceSheetforProviders.pdf http://aidsnet.org/wp-content/uploads/2021/11/3-cabenuva-nov-19-2021-version.pdf Reach out to Dr. Floyd here: https://www.linkedin.com/in/carlycloudfloyd/
…
continue reading
130 episodios
MP3•Episodio en casa
Manage episode 331887042 series 3265313
Contenido proporcionado por Political Pharmacist and Eric Geyer. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Political Pharmacist and Eric Geyer o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Cabenuva seemed to be a cure for adherence issues while treating HIV, so why is accessing it so hard? Dr. Carly Floyd joins the podcast to discuss issues with Cabenuva billing that has negatively impacted many patients, providers and clinics around the US. What seems like it should be simple approval process has turned into a medical billing nightmare that limits patients access, costs some clinics to lose money and has been a major issue with how we treat HIV. Increased opacity is never good in healthcare billing. Join AAHIVM here: https://aahivm.org/ Read more on Cabenuva issues here: https://aahivm.org/wp-content/uploads/2021/03/Long-Acting-ARVs-_Final-2-25-21_PDF.pdf https://www.floridahealth.gov/diseases-and-conditions/aids/adap/_documents/FINAL5BarrierstoLA-ARVsResourceSheetforProviders.pdf http://aidsnet.org/wp-content/uploads/2021/11/3-cabenuva-nov-19-2021-version.pdf Reach out to Dr. Floyd here: https://www.linkedin.com/in/carlycloudfloyd/
…
continue reading
130 episodios
Todos los episodios
×Bienvenido a Player FM!
Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.